Bank Julius Baer & Co’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,420
Closed -$291K 879
2020
Q3
$291K Sell
3,420
-12,222
-78% -$618K ﹤0.01% 458
2020
Q2
$554K Buy
+15,642
New +$457K 0.01% 348

Bank Julius Baer & Co's IMMU Position: Q4 2020 in Review

Bank Julius Baer & Co sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 3,420 shares — an estimated $291K sold.

Bank Julius Baer & Co first reported a position in IMMU in Q2 2020 and held it in 2 quarters. The position peaked at $554K in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Bank Julius Baer & Co reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Bank Julius Baer & Co sold 3,420 Immunomedics Inc shares in Q4 2020, an estimated $291K.
  • Bank Julius Baer & Co first reported a position in Immunomedics Inc in Q2 2020 and held it in 2 quarters.
  • Bank Julius Baer & Co's Immunomedics Inc position peaked at $554K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Bank Julius Baer & Co's 13F filing for Q4 2020, filed 12 Feb 2021.